Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/23/2025 16:12 PDT] Alto Neuroscience, Inc. (NYSE:anro), Up By 100% ($2.53) After BUYINS.NET SqueezeTrigger Report Released on Friday, May 2nd 2025 at a Price of $2.53.
• [05/23/2025 12:04 PDT] Alto Neuroscience, Inc. (NYSE:anro), Up By 100% ($2.52) After BUYINS.NET SqueezeTrigger Report Released on Friday, May 16th 2025 at a Price of $2.52.
• [05/22/2025 07:25 PDT] anro Expected to Trade Down After Bearish Patterns Develop
• [05/16/2025 10:29 PDT] anro SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [05/02/2025 13:20 PDT] anro SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [04/15/2025 14:36 PDT] Alto Neuroscience, Inc. (NYSE:anro), Up By 100% ($2.03) From $2.03 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/09/2025 07:19 PDT] anro Expected to Trade Up After Bullish Patterns Develop
• [04/07/2025 21:16 PDT] Market Maker Surveillance Report. anro, Winning Stocks With Lowest Price Friction For Monday, April 7th 2025
• [03/31/2025 10:29 PDT] Alto Neuroscience, Inc. (NYSE:anro), Down By 100% ($2.8) From $2.8 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions